Teva reaches $4.25 billion settlement over alleged role in opioid crisis

Teva Pharmaceuticals will pay up to $4.25 billion in a nationwide settlement over its alleged role in the opioid crisis. 

The drug giant announced Tuesday that the settlement with several state and local governments includes supplying up to $1.2 billion in Narcan, a nasal spray used to reverse opioid overdoses. The money will be paid out over 13 years.

Teva will also pay $100 million to Native American Tribes.